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Background: Pediatric trials to add missing data for evidence-based pharmacotherapy
are still scarce. A tailored training concept appears to be a promising tool to cope with
critical and complex situations before enrolling the very first patient and subsequently to
ensure high-quality study conduct. The aim was to facilitate study success by optimizing
the preparedness of the study staff shift.
Method: An interdisciplinary faculty developed a simulation training focusing on the
communication within the informed consent procedure and the conduct of the
complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation
facility. Scenarios were video-debriefed by an audio-video system and manikins with
artificial blood simulating patients were used. The training was evaluated by participants’
self-assessment before and during trial recruitment.
Results: The simulation training identified different optimization potentials for improved
informed consent process and study conduct. It facilitated the reduction of avoidable
errors, especially in the early phase of a clinical study. The knowledge gained through the
intervention was used to train the study teams, improve the team composition and optimize
the on-ward setting for the FP-7 funded “LENA” project (grant agreement no. 602295). Self-
perceived ability to communicate core elements of the trial aswell as its correct performance of
sample preparation increased significantly (mean, 95%CI, p ≤ 0.0001) from 3 (2.5–3.5) to four
points (4.0–4.5), and from 2 (1.5–2.5) to five points (4.0–5.0).
Conclusion: An innovative training concept to optimize the informed consent process and
study conduct was successfully developed and enabled high-quality conduct of the
pediatric trials as of the very first patient visit.
Keywords: pediatrics, communication, study conduct, pharmacokinetic/pharmacodynamic, patient recruitment,
simulation training, clinical study
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INTRODUCTION
Despite the European Pediatric regulation aiming to bring
evidence-based drug therapy to the vulnerable pediatric
population, its effects are still lacking (Samiee-Zafarghandy
et al., 2014). Even 13 years after the regulation got into force,
there is still a high demand for well-investigated drug
therapies and tailored medication for the pediatric
population. Highly required pediatric trials to add missing
data for evidence-based pharmacotherapy are still scarce for
this vulnerable population.
About 25% of randomized controlled trials in adults and up to
40% of pediatric trials are discontinued prematurely (Kasenda
et al., 2014; Schandelmaier et al., 2017) because of insufficient
patient recruitment (Pica and Bourgeois, 2016). Parents are more
reluctant to consent on behalf of their children than for
themselves (Caldwell et al., 2003), making recruiting for
pediatric trials challenging. Key elements are the quality of the
informed consent process (Koyfman et al., 2016), and a well-
planned and well-organized study conduct (Pica and Bourgeois,
2016). In particular, avoidable errors occur mainly at the
beginning of a clinical study. As a consequence, potentially
eligible patients get lost in the early phase of the study
(Taekman et al., 2010).
Simulation training in healthcare (Chopra et al., 1994;
Schwid et al., 2002; Windsor et al., 2008) has shown that
critical steps in complex situations can be improved
(Shapiro, 2004; Wright et al., 2005). Simulating experiences
with patients and relatives, and systematically analyzing these
experiences prevents avoidable mistakes in practice. The
principle is well established in medical education in many
areas. Simulation training improves teamwork and critical
thinking within clinical teams. The training has
demonstrated its usefulness by increased guideline
compliance and fewer process deviations (Shapiro, 2004;
Windsor et al., 2008; McGaghie et al., 2011). Simulation
training for the preparation of a clinical trial is a promising
tool that appears to be robust to improve study protocol
compliance, communication and study conduct. It is an
auspicious tool to ensure high-quality study conduct to cope
with critical and complex situations before enrolling the very
first patient.
In the context of the pediatric studies within the LENA
project (Labeling of Enalapril from Neonates up to
Adolescents, FP7/2007-2013 Grant Agreement No. 602295)
(Bajcetic et al., 2019) protocol compliance, obtaining
informed communication and optimal study conduct were
considered challenging. According to the agreed Pediatric
Investigation plan, seventy percent of patients were
mandatory to be younger than one year of age. Therefore,
challenging recruitment and tough blood sampling were
likely to occur within the LENA project, and avoidable errors
were supposed to cause a substantial negative impact.
This study-specific prerequisite of the LENA project
motivated us to develop and conduct a tailored simulation
training in preparation for the clinical trials. This manuscript
describes how this simulation-based training for study teams was
developed and applied, which experiences were gained and how
the participating study teams assessed the effects. Thus, it allows
other groups to apply our comprehensive, patient/parent
centered and innovative approach to their own clinical trials.
METHODS
Pedagogical Principles
The aim of the intervention was to facilitate study success by
optimizing the preparedness of the study staff, in other words to
shift the learning curve with critical study elements toward the
pre-study period. Thus, the training intervention should enable
-on the one hand- practical experience and familiarization of the
study staff and on the other hand, allow for optimization of the
study procedures and documents toward the study staff’s needs
in practice. The structure and setting of medical simulation team
training seemed promising for these aims. The conceptual
framework, which best describes this type of experiential
learning is Kolb’s learning circle (Kolb, 2014). It is
characterized by the four learning phases: concrete experience,
reflection, conceptualization, and experimentation. In our
training this was implemented by simulation scenarios, in
which study staff gathered experience with communication
challenges or pharmacokinetic/pharmacodynamic (PK/PD)
sampling procedures ( concrete experience). This experience
was recapitulated in the structured scenario debriefing which
included the reviewing of selected video sequences of the
scenario ( reflection). Moreover, potential improvements
were identified. Plans on how to implement these
improvements (e.g., by reorganizing the teamwork, adjusting
the procedures etc.) were built ( conceptualization). These
plans were then applied and tested in the consecutive
scenarios ( experimentation). The process of briefing,
scenario, debriefing with development of an improvement
plan and application of the improvements within the
consecutive scenario was repeated iteratively. The practical
application of this didactic principle within our training is
further illustrated in Supplementary Material S1. All
participants followed all scenarios and participated in all
debriefings, thus learning was not limited to the own hands
on experience but included also learning based on the
observation and debriefing of other scenarios. The debriefing
was facilitated by simulation and communication trainers using
methods and a structure recommended for trainings of technical
skills, teamwork training, and inter-professional collaboration
(Eppich and Cheng, 2015). This PEARLS method helps to
facilitate an active, collaborative, self-directed and learner-
centered learning. Thus it was very useful for leveraging our
participants’ high level of clinical trial experience for improving
individual and team competencies as well as developing study
site specific plans for mastering the critical study elements.
Amongst other benefits, this innovative training approach
stands out over unidirectional information transfer or simple
repetitive drills as it enables study teams to find and internalize
how the study protocol can be best realized in the working
environment and situation of their site. This is particularly
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TABLE 1 | Learning objectives.
Learning objectives
Scenario 1: Parents do not see the need for the study or find the requirements
too rigorous
Establish a setting for the communication that is quiet, friendly and not associated with previous “bad news” experiences of
the parents
Identify and eliminate risks like emotional states that prevent information transfer and subsequently successful
communication
Communicate the expected benefits of the mini tablets (IMP) over the currently used formulation of enalapril (e.g., facilitated
by demonstrating the mini tablets) and the expected burden and risks involved in study participation in a language that meets
the parents’ needs
Detect motives for a rejection of research in general or the proposed study in particular and provide relevant information in a
patient-centred and empathic way
Scenario 2: Parents are not able to follow the informed consent discussion Learning objectives 1-3 plus
Identify barriers to comprehension and use supportive material like picture card etc.
Facilitate parental questions and expression of concerns
Prioritize on key information with highest importance for parents
Schedule a follow-up appointment, if needed
Scenario 3. Lack of a trustful relationship with the parents Learning objectives 1-3, 6 plus
Identify barriers to trust
Use confidence-building body language and positive vocabulary (e.g., “research” instead of “clinical trial”)
Actively involve study nurse, referring physician with lower barriers or pre-existing strong relationship to parents
Scenario 4: Fear of invasive medical procedures Learning objectives 1-3, 6 plus
Identify reasons for fear without downplaying or concealing risks and burdens
Explain how risks and burdens are kept to a minimum
Point out that the study protocol has been approved by the ethics committee.
Scenario 5: Uncooperative clinical staff Learning objectives 1-3
Identify causes of negative reactions and address each single concern in a respectful way
Define benefits and justify risks and burdens for participants and efforts for clinical and study staff
Explain how risks, burdens and efforts are kept to a minimum
Apply conflict management methods
Scenario 6: Lack of confidence in the process by members of the study staff Learning objectives 1-3
Identify the exact cause behind the lack of confidence
Evaluate the need for information and provide it in respectful way
Make own personal beliefs about the study transparent


































helpful with regard to the diversity of study sites commonly
found in international multi-center trials.
Learning Environment
The simulation intervention was part of the overall training
concept for the LENA pediatric trials that is depicted in the
Supplementary Material S2 and described in detail elsewhere
(Ciplea et al., 2018). For the 1.5-days training, the investigators,
research coordinators, and study nurses of all sites visited the
Medical Simulation Center Salzburg (Austria), three months
before the expected “first patient first visit”. The setup
comprised a training room reflecting the typical working
environment at the corresponding study sites. For this
purpose, the equipment, setting, room size etc. at the
participants’ sites was investigated in advance and
reconstructed by props, paravents, clinical and lab equipment.
Further, a one-way mirror control booth was used for observation
and assessment by the simulation operators and in a debriefing
room all delegates currently not actively involved observed the
scenario via live streaming. Parents and siblings were role-played.
The simulation manikins were prepared to allow for the sampling
of artificial blood. For sample processing procedures, blood
substitutes and authentic tubes, stickers, and forms of the
LENA clinical trials were utilized to achieve high-fidelity.
Training Objectives and Scenario
Development
Great importance was attached to the identification of the most
relevant training objectives and the design of highly realistic
scenarios, not only to address the most critical study elements
but also to achieve a high level of training motivation and
success. An inter-professional, interdisciplinary faculty of
eleven members with expertize in the field of pediatrics, Good
Clinical Practice (GCP), trial management, communication
training, bioanalysis, clinical pharmacy, and patient
representatives was formed. For the identification of critical
challenges, a pre-mortem analysis was used (Mitchell et al.,
1989), starting with the hypothetical assumption that a
project has failed, and working backwards to determine what
could have potentially lead to the failure of the project. This
process identified the following potential threats as most relevant
to the successful conduct of the pediatric LENA trials: 1) a very
young (70% < 1 year of age) and very vulnerable target
population with severe cardiac disease 2) frequent visits and
12 months duration of study participation, 3) a high number of
blood samplings with 4) complicated pre-analytical procedures.
“Communicating the importance of the trials and key trial
elements with parents, clinical and study staff” and “blood
sampling and processing” were consequently defined as most
critical study elements. Obviously, these are most important in
any PK/PD study, however the identification of the potential
threats allowed the deduction of very relevant and realistic
scenarios as well as concrete training objectives. Developed
scenarios and objectives are summarized in Table 1.
Training Format
The 1.5-days training was structured in three parts. In part one,
presentations were given on key elements of the study (e.g., number
of visits, frequency of blood drawings etc.) by a pharmacist, on
communication techniques by a communication trainer with
specific health care background, on PK/PD sampling and
documentation procedures by a pharmacist as well as on the
simulation approach by the training director. Furthermore, the
participants familiarized themselves with the “LENA”-study specific
documents and equipment (e.g., orodispersible mini-tablets, the
informed consent form, sampling and documentationmaterial) and
the training environment. Part two and three took place at the
consecutive day. In part two, PK/PD procedures were simulated.
The study teams had to perform the blood sampling, the complex
and time-critical pre-analytic procedures to be performed on ward
as well as the comprehensive documentation under realistic
conditions and in strict accordance to the study protocol. As
many different tubes per patient and time point were needed
and a deviation from protocol could render the samples invalid,
workload as well as time and success pressure of this task were high.
The participants were guided stepwise from practical
demonstrations over deliberate practice of single tasks toward
full runs of sampling and pre-analytic procedures in the
simulation scenarios. Within two to three rounds, the difficulty
of scenarios was gradually increased to a realistic setting, which also
included the simulation of stressors like emotionalized parents or
interrupting clinical staff by actors. Sampling, labeling, centrifuging,
pipetting, cooling, documentation and keeping the time limits were
meticulously monitored in every scenario. Within debriefing,
observed deviations from protocol, potential reasons for failure
and potential for improvement were worked out in a learner-
centered manner.
In the third and last part, scenarios with communication
challenges were conducted. The participants could select the
situation of their scenarios between informed consent
conversation or critical communications with either clinical
staff or study staff. However, the particular tasks and
challenges of the scenarios (see Table 1) were not disclosed to
the participants in advance. Parents and siblings were role-played
and to add complexity distractors such as crying manikins, urgent
telephone calls, annoying behavior of siblings were added. The
conversations were conducted according to the standard situation
of the participants, which included teams of investigator plus
research nurse and of principal and sub-investigators.
Participants could speak in their mother language or English.
Where needed, the communication trainer was supported by a
simultaneous translator. Different to the PK/PD scenarios, the
performance could not be dichotomously classified correct or
incorrect. Thus, the debriefing focused on how successful
communication strategies were used in the respective scenario
and what could be improved. It was encouraged to use lay
language, open-ended questions, active and reflective listening
including positive body language, without interrupting, showing
empathy and compassion, and joint decision-making to ensure
that the patient’s preferences, needs and values were respected.
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Prospective Evaluation of the Simulation
Training by Self-Assessment Survey
As all study teams should benefit by this training intervention, a
controlled study to proof its effects was not feasible within this
project. Thus, we conducted a prospective survey study to assess the
pre-training ability and preparedness of participants as well as the
perceived training impact on knowledge, attitudes and working
practice. The survey study was approved by the ethical
committees of Salzburg state government, Austria (study no. 415-
E/1909/2–2015) and Heinrich Heine University Duesseldorf,
Germany (study no. 5138). Training participants were surveyed
at four time points: Before and directly after the training to assess
pre-training competencies and immediate training effects, and at
study start plus upon 70% of planned patients’ recruitment to
determine if the training effects were still present when needed
and how they were rated after applying the trained skills. Details on
the content of each questionnaire are provided in Supplementary
Material S3. The five-point Likert-Scale (1  very poor/strongly
disagree, 5  very good/strongly agree) ratings were evaluated by a
Wilcoxon test using the statistical software environment R (version
3.3.3). The Wilcoxon signed-rank test was applied to the differences
of the pre- and post-training competencies. For each test, a statistical
level of significance of p  0.05 was considered.
Post-Hoc Analysis of Participant
Recruitment and Protocol Compliance in
Pharmacokinetic/Pharmacodynamic
Sampling
Encouraged by the positive feedback on the training intervention
and to understand if we succeeded in shifting the learning toward
the pre-initiation period, we performed a post-hoc analysis of
learning effects within our trials. For this purpose, the rate of
recruitment for all sites over the complete recruitment period was
analyzed. Additionally, the number of PK/PD samples with
protocol deviations during the first three months was analyzed




In four 1.5-days trainings between July and October 2015, twenty-
three participants from six study sites were trained. In total, 13
(56.5%) physicians and 10 (43.5%) (study) nurses joined the
training. 60.9% of the participants had more than 5 years of
experience in clinical studies. Details on the demographics of
the participants are provided in Supplementary Material S4.
The scenarios were conducted in Dutch (Samiee-Zafarghandy
et al., 2014), English (Koyfman et al., 2016), German (Samiee-
Zafarghandy et al., 2014), Hungarian (Kasenda et al., 2014), and
Serbo-Croatian (Schandelmaier et al., 2017). When requested to
select between communication challenges with the informed
consent situation or critical situations with concerned clinical or
study staff, all teams decided for the first.
Needs and Plans for Improvement Identified
With the Scenarios
Although in general, the competency of the participants in providing
information on the key aspects of the trials in a patient/parent
centered manner was good, some reoccurring opportunities for
improvement may also be relevant for other projects.
Lay language was used in all conversations, but study elements
were mostly described in very technical medical language. It was
encouraged to aim for a balanced speaking time (50:50) between
parents and study team, to answer all questions of the parents and to
FIGURE 1 |Results of the conducted self-assessment survey. Panel (A) depicts the participants rating on their competencies before and two days after the training
concerning communication and PK/PD sampling. Results are depicted as Hodges Lehmann Estimator (HLE) with corresponding CI using a 5-point Likert-scale (1  very
poor, 5  very good, *p < 0.0001, ** p  0.0001, ↑p  0.0002). Panel (B) illustrates the perceived long-term effects on attitude, knowledge, and working practice. Timepoints of determination were immediately after the simulation training (“after the training”), short before individual study start at each site (“before starting the study”)
and at time point of 70% of anticipated study-wide patient recruitment (“during recruitment”).
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keep the focus on practical study elements (e.g., participants’
obligations, benefits, risks etc.) rather than scientific background
information. Only two participants achieved balanced speaking
time. In average, health care professionals (HCPs) spoke 66 ± 14%
of the time. Interestingly, in conversations strongly dominated by
HCPs, the focus tented to lay on scientific terms and parental
questions remained unanswered partly. Intendedly added stressors
like annoying siblings or uncooperative parents strongly impacted the
conversation. Even if HCPs obviously were aware of the situation and
tried to counteract specifically, most were surprised to see within the
debriefing how these stressors that they face commonly in pediatrics,
impacted them up to aggressive emotions. The practical
demonstration of the easy-to-use orodispersible mini-tablets was
perceived very helpful to illustrate the study benefits. Upon
reflection and discussion of these experiences most participants
planned to put more emphasis on creating a positive situation and
prevent stressors, e.g., by organizing an extra person to look after
siblings or by scheduling an additional appointment. Moreover,
several participants concluded to change their approach for these
conversations from a mainly unidirectional description of all study
details toward a very brief introduction of the key study elements
immediately followed by more active involvement of the parents and
addressing their questions.
In the first round of PK/PD sampling, 62.5% of all samples
were prepared in accordance with the protocol. Exceeding the
time limits, incorrect sample preparation and incomplete
documentation were the main issues. Potential sources for
protocol deviations revealed by video-assisted reflection of the
scenarios included under-staffing, sub-optimal arrangement of
the setting, insufficient assignment of tasks and communication
affecting teamwork in general but particularly the hand-over
between sampling and processing. Thus, for the consecutive
rounds team size was increased from two to three or four
members, responsibilities were shared, and the working
environment was refined. Although in round two distractors
like crying children, parents asking questions and emergency
calls were integrated to increase realism and stress, the quality of
tasks improved substantially. The strict timelines between
sampling to sample freezing for PD parameters of ≤15 min
were met in more than 91%. The final comprehensive sample
preparation increased to 97.4% in average, while trial
documentation was accurate in 100%.
Results of the Self-Assessment Survey
All 23 participants of the training consented to take part in the
survey-based evaluation. The response rate was 100% at the first
three time points and 95% at the last. The total follow-up time
ranged between 19 and 23 months after the simulation training.
Both, communication skills as well as trial-specific sampling and
sample preparation abilities were significantly higher self-
assessed immediately after training (Figure 1A).
The self-assessment survey indicated a significant increase of
the ability to communicate the core elements of the clinical trial
(p  0.0001) and the preparation to deal with trial-related
communicative challenging situations (p  0.0002). The abilities
regarding sampling and sample preparation procedures improved
(p< 0.0001) toward “good” (scale level 4) or “very good” (scale level
5) after the training (Figure 1A). The training’s impact on
knowledge, attitude and working practice was rated “good” or
“very good” at all time points of assessment (Figure 1B). The
approach of simulation-based training in preparation for clinical
trials was unanimously perceived as suitable.
Post-Hoc Analysis of Participant
Recruitment and Protocol Compliance in
Pharmacokinetic/Pharmacodynamic
Sampling
Total number of recruited patients and rate of recruitment differed
substantially between all sites (Figure 2A). However, all sites showed
FIGURE 2 |Recruitment rates per site. Both panels show the recruited patients per study site over the total study period. In panel (A) each patient is represented by
one symbol, patients of one site are connected by lines. Panel (B) shows normalized data, the percentage of patients recruited over the percentage of each site’s
recruitment time. The dashed line is a non-linear curve fit of all curves indicating that the mean recruitment rate is highest at recruitment start.
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their top recruitment rate right at start of recruitment (Figures 2
A,B). The evaluation of proportion of PK/PD samples with protocol
deviations revealed a very high-quality level in general. All sites
started with levels of 95 to 100% of correct samples, which was above
or in the range of their overall performance (Table 2) indicating no
lag time to top quality rates in PK/PD sampling.
DISCUSSION
This is the first report on the development and application of
simulation-based training for improving the informed consent
process and the PK/PD sampling in clinical trials. Our innovative
approach combined a patient/parent centered, interdisciplinary
process to identify most relevant protocol specific hurdles and an
experiental training programutilizing technical and didacticmethods
of medical simulation. It allowed us to identify relevant hurdles for
successful study conduct, optimize the composition of teams and
improve their preparedness, evaluate and improve the feasibility of
the study processes and adopt the working environment at the study
sites for the expected challenges based on the training experiences.
The participants rated the training as very helpful, and their
preparedness for the challenges of the study classified significantly
higher after the intervention.Moreover, very high quality of sampling
and on-ward sample preparation was achieved. This training
approach seems a suitable risk mitigation tool and valuable
addition to standard methods in clinical trial preparation.
We expected that getting informed consent and PK/PD
sampling, including sample processing and its documentation to
be the most significant challenges to successful study conduct. On
the one hand, this was due to very young and partly critically ill
patient population and the complex sampling of the LENA
pediatric trials, and on the other hand as a common
phenomenon, particularly in trials with minors.
Participant recruitment in timely and targeted manner is a
major if not the most important success factor for pediatric and
other clinical trials (Denhoff et al., 2015) and the oral
communication in recruitment and the informed consent
process is of utmost importance (Menon et al., 2012;
Treasure and Morton, 2012). It is well shown that there is a
relevant probability, that written study information is
insufficiently comprehended by most patients (Lagler et al.,
2015) and that patients understand study contents better when
the information giving physicians receive communication
training (Kinnersley et al., 2013; Glaser et al., 2020). It is
plausible that the same applies to parents that consent by
proxy. Further, according to a large meta-analysis of 72
manuscripts comparing strategies to improve participant
recruitment, oral communication on the study intervention
was one of two factors with a significant impact on
recruitment (Treweek et al., 2018). Nevertheless, doctors
often do not receive formal training on how to obtain
informed consent (Mason and Allmark, 2000).
Moreover, sampling and processing quality is a major issue for
most PK studies. Presumably, over 10 million Euros of funding
are lost every year in clinical trials in the European Union due to
pre-analytical and analytical problems (Lippi et al., 2016). The
vast majority of specimens (over 90%) rejected by laboratories are
unsuitable due to incorrect procedures for collection and
transportation (Lippi et al., 2016).
The standard method to prepare study staff for a specific study
includes monitoring visits and investigator meetings, both showing








Site 1 Early phase of recruitment 1st month 39 2 37 95.0% 88.3%
2nd month 20 6 14 70.0%
3rd month 12 0 12 100.0%
Full observation period 228 28 200 87.7%
Site 2 Early phase of recruitment 1st month 26 0 26 100.0% 100.0%
2nd month 35 0 35 100.0%
3rd month 11 0 11 100.0%
Full observation period 304 1 303 99.7%
Site 3 Early phase of recruitment 1st month 25 0 25 100.0% 100.0%
2nd month 27 0 27 100.0%
3rd month 12 0 12 100.0%
Full observation period 272 0 272 100.0%
Site 4 Early phase of recruitment 1st month 35 0 35 100.0% 100.0%
2nd month 23 0 23 100.0%
3rd month 19 0 19 100.0%
Full observation period 172 1 171 99.4%
Site 5 Early phase of recruitment 1st month 140 6 134 95.8% 98.3%
2nd month 102 1 101 99.0%
3rd month 82 0 82 100.0%
Full observation period 1,001 7 994 99.3%
Full observation period reflected 18 months (January 2016 until June 2017).
PK/PD, pharmacokinetic/pharmacodynamic.
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no or little effect in similar studies (Liénard et al., 2006;Mitchell et al.,
2020). It is well known that both, slow participant recruitment and
failure to adhere to the protocol are generally most severe at the
beginning of trials (Taekman et al., 2010). Besides low familiarity with
the protocol and need for “rehearsal”, false self-assessment of the
study staff’s preparedness for the challenges of the trial and other
human factors as well as weaknesses of the study protocol and data
assessment documents and processes seem to impact the learning
curve with a clinical trial (Taekman et al., 2010). High-fidelity human
patient simulators have previously been used to evaluate the feasibility
of study protocols and to train study coordinators in other tasks with
significant effects on the confidence of the study staff and indicating
overconfidence as a potential risk factor for the study success. The
majority of protocol deviation takes place at the beginning of trials
(Taekman et al., 2010). In our simulation-based training intervention,
we combined protocol and document improvement with the
experiential training of our study staff before the trial start. Our
approach allowed practical experience and (self-) reflection of the
preparedness for the study procedures before the study initiation.
Moreover, we gathered valuable information on potential challenges
and solutions in the informed consent conversation as well as PK/PD
sampling, processing and documentation. The insights and plans for
improvement of documents, procedures, teamwork etc. gathered
within the training were integrated into the subsequent training in
an iterative manner.
According to our self-assessment survey, the training
participants felt well prepared for challenges in
communication and PK/PD sampling and sample
preparation by the training intervention. This favorable
judgment of the training effects remained unchanged, even
after the majority of patients had been recruited. We are aware
of the limitations of self-assessment of competence, and
clearly, a controlled study design is needed to confirm the
effects of the intervention on the study staff’s competences.
Yet, several observations we made throughout the LENA trials
are in line with the observed training effects. Although the
overall recruitment rate differed between our sites, none
showed a low recruitment rate at the beginning of the trial.
The rate was quite linear with a tendency to a plateau at the end
of the recruitment period. The site with the highest
recruitment even showed a logarithmic shape of recruitment
over time (Figure 2). Thus, the learning curve effect on
recruitment described in many other studies and
systematically analyzed by Taekman was not observed
(Taekman et al., 2010). Overall, the deviation rate
concerning PK/PD sampling and preparation was only 2.3%
without any time lag to reach this quality level. The proportion
of invalid samples is usually much larger, even in the less
challenging setting of studies in adult patients (Ng et al., 2017;
Gioia et al., 2016). Whether this observation is an effect of the
simulation intervention cannot be clarified due to the missing
control group. However, the results are remarkable, given the
fact that one third of pediatric trials are delayed due to poor
recruitment, one fifth is discontinued (Pica and Bourgeois,
2016) and an optimum of protocol compliance and
documentation correctness is normally reached after
enrollment of 20–80% of participants (Taekman et al.,
2010). We were very aware of this limitation when planning
and conducting the intervention and its evaluation; however,
we could not risk withholding the potential benefits of the
intervention from parts of our sites.
CONCLUSION
Our innovative training concept to optimize the informed
consent process and PK/PD sampling was associated with
successful recruitment and a high-quality study conduct with
a complex study protocol and in a very challenging population.
The strengths of this approach include the recognition of
weaknesses in processes and documents as well as the
opportunity to identify and practice critical procedures
before the study initiation. The effort to bring together a
faculty of experts for simulation-based training, clinical trial
experts and patient advocates seemed to pay off in our setting. It
may be a very valuable complementary instrument to other
methods for preparing study sites also in other challenging
study settings. The developing process of this training
intervention as described in this manuscript can be used as a
template by other research consortia or study sponsors. The
preventable mistakes identified in our trainings maybe relevant
for other studies. Therefore, although a confirmation of the
specific training effects in comparison to other or no
intervention was not feasible in our setting, our results may
ultimately help to improve the preparedness of study sites in
other trials, particularly in the challenging setting of pediatric
populations.
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